Asia Pacific Hemostats Market Size study, by Type (Thrombin Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, Others) by Formulation (Matrix and Gel Hemostats, Sheet

Asia Pacific Hemostats Market Size study, by Type (Thrombin Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, Others) by Formulation (Matrix and Gel Hemostats, Sheet and Pad Hemostats, Sponge Hemostats, Powder Hemostats, Others) by Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Others) and Country Forecasts 2022-2032

Asia Pacific Hemostats Market is valued approximately USD 510 million in 2023 and is anticipated to grow with a healthy growth rate of more than 8.84% over the forecast period 2024-2032. Hemostats are surgical tools used to control bleeding by clamping blood vessels or tissue. They are designed to temporarily restrict the flow of blood or other bodily fluids during surgical procedures or medical interventions. Hemostats come in various shapes and sizes, but they typically feature hinged, scissor-like handles with locking mechanisms and serrated jaws for better grip. Additionally, the key trend of Asia Pacific Hemostats Market is growing awareness and adoption of minimally invasive surgeries which is anticipated to support the market growth. There is a growing preference for minimally invasive surgical procedures in the Asia Pacific region due to their benefits, such as shorter hospital stays, faster recovery times, and reduced post-operative complications. Hemostats play a crucial role in minimally invasive surgeries by enabling precise hemostasis in confined spaces, driving their demand in this segment.

Moreover, the Asia Pacific region is witnessing a rise in the number of surgical procedures, fueled by factors such as a growing aging population, increasing prevalence of chronic diseases, and rising healthcare expenditure. Surgical procedures ranging from cardiovascular surgeries to orthopedic surgeries and general surgeries require effective hemostasis, thereby driving the demand for hemostats. Also, advancements in hemostatic technologies are driving the Asia Pacific Hemostats Market. Manufacturers are introducing innovative hemostatic agents, sealants, and devices with improved efficacy, safety, and ease of use. These advancements include the development of topical hemostatic agents, absorbable hemostats, and hemostatic patches, which are gaining traction in the Asia Pacific market. However, side effects and allergic reactions associated with hemostats are expected to hinder the market growth during the forecast period 2024-2032.

The key Countries considered for the Asia Pacific Hemostats market study includes China, India, Japan, South Korea, Australia and Rest of Asia Pacific. In 2023, China was the largest regional market in terms of revenue. China is continuously expanding its healthcare infrastructure to address the healthcare needs of its vast population. This includes the construction of new hospitals, specialty clinics, and outpatient centers, as well as the modernization of existing healthcare facilities. The expansion of healthcare infrastructure is driving the demand for hemostats and other surgical products in the country. Moreover, India is expected to grow with the highest CAGR during the forecast period 2024-2032.

Major market player included in this report are:
Nipro Corporation
Hoya Corporation
Terumo
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:
By Type
Thrombin Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Others

By Formulation
Matrix and Gel Hemostats
Sheet and Pad Hemostats
Sponge Hemostats
Powder Hemostats
Others
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Others
By Region:
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.